PrecisePK Therapeutic Drug Monitoring Software
Description
A leading Bayesian therapeutic drug monitoring software for Model-Informed Precision Dosing (MIPD), specializing in vancomycin AUC dosing and featuring real-time monitoring and data-driven analytics for acute kidney injury management.
Market positioning
Leading therapeutic drug monitoring software with strong focus on vancomycin dosing and Bayesian precision dosing
Use cases
Medical and pharmaceutical professionals, pediatricians, neonatologists, pharmacists, and hospital clinical staff involved in therapeutic drug monitoring
Features
Industry-leading vancomycin AUC dosing accuracy
Validated by independent research
Endorsed by GlobalRPH
Fully compliant with 2020 ASHP/IDSA Vancomycin Guidelines
Established history in the industry (formerly TDMS)
Trusted by major healthcare institutions
Multi-language support for global use
Comprehensive compliance certifications
Real-time AKI prediction capabilities
Pros and cons
Based on: (AI summary)
Pros
- Industry-leading vancomycin AUC dosing accuracy
- Validated by independent research
- Endorsed by GlobalRPH
- Fully compliant with 2020 ASHP/IDSA Vancomycin Guidelines
- Established history in the industry (formerly TDMS)
Cons
- Pricing information not readily available
- May require subscription commitment
- Primarily focused on vancomycin monitoring